Severe arteriospastic disease secondary to use of ergot preparations.
D001158:Arteries; D002317:Cardiovascular Agents; D004194:Disease; D004876:Ergot Alkaloids / Q000009:adverse effects*; D006801:Humans; D014652:Vascular Diseases
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids
ARTERIES/diseases; ERGOT ALKALOIDS/injurious effects